Q3  2024 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 7.29% |
121,252 |
0.37 |
≡ |
Greenhaven Associates |
Add 1.46% |
242,545 |
0.18 |
≡ |
Kahn Brothers Group |
Reduce 0.69% |
8,279 |
0.09 |
≡ |
Richard Pzena - Hancock Classic Value |
Add 0.19% |
1,692 |
0.01 |
Q2  2024 |
≡ |
Michael Burry - Scion Asset Management |
Sell 100.00% |
125,000 |
7.64 |
≡ |
Richard Pzena - Hancock Classic Value |
Reduce 30.09% |
385,941 |
2.12 |
≡ |
Leon Cooperman |
Sell 100.00% |
300,000 |
0.79 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 6.41% |
113,965 |
0.38 |
≡ |
Greenhaven Associates |
Add 2.14% |
349,086 |
0.29 |
≡ |
Kahn Brothers Group |
Reduce 0.38% |
4,594 |
0.05 |
Q1  2024 |
≡ |
Michael Burry - Scion Asset Management |
Add 25.00% |
25,000 |
1.53 |
≡ |
Richard Pzena - Hancock Classic Value |
Reduce 12.84% |
188,900 |
0.71 |
≡ |
Samantha McLemore - Patient Capital Management |
Reduce 5.94% |
112,256 |
0.35 |
≡ |
Greenhaven Associates |
Add 1.11% |
178,455 |
0.10 |
≡ |
Kahn Brothers Group |
Reduce 0.82% |
9,922 |
0.09 |
≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
7,369 |
0.01 |
Q4  2023 |
≡ |
Michael Burry - Scion Asset Management |
Buy |
100,000 |
5.44 |
≡ |
Greenhaven Associates |
Add 22.40% |
2,948,512 |
1.62 |
≡ |
Leon Cooperman |
Reduce 57.14% |
400,000 |
0.97 |
≡ |
Steven Romick - FPA Crescent Fund |
Add 21.20% |
778,922 |
0.67 |
≡ |
Kahn Brothers Group |
Reduce 0.52% |
6,316 |
0.05 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 0.37% |
6,902 |
0.02 |
≡ |
Lee Ainslie - Maverick Capital |
Buy |
7,369 |
0.01 |
Q3  2023 |
≡ |
Greenhaven Associates |
Add 20.00% |
2,193,883 |
1.17 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 24.99% |
376,413 |
0.91 |
≡ |
Steven Romick - FPA Crescent Fund |
Add 2.85% |
101,769 |
0.07 |
≡ |
Kahn Brothers Group |
Add 0.74% |
8,878 |
0.06 |
Q2  2023 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 914.84% |
1,357,616 |
3.48 |
≡ |
Bill Miller - Miller Value Partners |
Sell 100.00% |
1,099,482 |
3.22 |
≡ |
Leon Cooperman |
Add 77.22% |
305,000 |
0.76 |
≡ |
Greenhaven Associates |
Add 8.82% |
889,450 |
0.54 |
≡ |
Bruce Berkowitz - Fairholme Capital |
Sell 100.00% |
82,500 |
0.32 |
≡ |
Kahn Brothers Group |
Reduce 0.88% |
10,747 |
0.07 |
Q1  2023 |
≡ |
Bill Nygren - Oakmark Select Fund |
Sell 100.00% |
4,012,000 |
4.45 |
≡ |
Greenhaven Associates |
Add 31.23% |
2,399,160 |
1.75 |
≡ |
Richard Pzena - Hancock Classic Value |
Reduce 15.16% |
262,884 |
0.83 |
≡ |
Bruce Berkowitz - Fairholme Capital |
Reduce 52.15% |
89,900 |
0.35 |
≡ |
Kahn Brothers Group |
Add 4.20% |
49,021 |
0.33 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 9.28% |
12,600 |
0.26 |
≡ |
Bill Miller - Miller Value Partners |
Add 6.66% |
68,614 |
0.20 |
≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
8,151 |
0.01 |
≡ |
Warren Buffett - Berkshire Hathaway |
Add 0.16% |
89,000 |
0.00 |
Q4  2022 |
≡ |
ValueAct Capital |
Sell 100.00% |
10,992,637 |
7.76 |
≡ |
Bill Nygren - Oakmark Select Fund |
Reduce 19.95% |
1,000,000 |
1.11 |
≡ |
Richard Pzena - Hancock Classic Value |
Reduce 13.27% |
265,329 |
0.73 |
≡ |
Greenhaven Associates |
Add 6.32% |
456,730 |
0.37 |
≡ |
Kahn Brothers Group |
Add 0.49% |
5,741 |
0.03 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 0.56% |
5,760 |
0.02 |
≡ |
Bruce Berkowitz - Fairholme Capital |
Reduce 0.98% |
1,700 |
0.01 |
≡ |
Lee Ainslie - Maverick Capital |
Add 34.15% |
2,075 |
0.00 |
Q3  2022 |
≡ |
Bill Nygren - Oakmark Select Fund |
Add 24.93% |
1,000,000 |
1.04 |
≡ |
Greenhaven Associates |
Add 10.09% |
661,950 |
0.58 |
≡ |
Richard Pzena - Hancock Classic Value |
Reduce 7.62% |
165,027 |
0.37 |
≡ |
Kahn Brothers Group |
Add 4.31% |
47,993 |
0.31 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 4.46% |
48,441 |
0.12 |
≡ |
Bruce Berkowitz - Fairholme Capital |
Reduce 1.02% |
1,800 |
0.01 |
≡ |
Lee Ainslie - Maverick Capital |
Buy |
6,076 |
0.01 |
Q2  2022 |
≡ |
ValueAct Capital |
Reduce 20.61% |
2,853,470 |
2.09 |
≡ |
Greenhaven Associates |
Add 22.18% |
1,191,580 |
1.18 |
≡ |
Kahn Brothers Group |
Add 14.67% |
142,651 |
0.88 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 30.58% |
31,800 |
0.72 |
≡ |
Leon Cooperman |
Add 107.89% |
205,000 |
0.65 |
≡ |
Bill Miller - Miller Value Partners |
Add 11.77% |
114,262 |
0.29 |
≡ |
Richard Pzena - Hancock Classic Value |
Add 5.61% |
114,945 |
0.24 |
≡ |
Bruce Berkowitz - Fairholme Capital |
Add 20.31% |
29,700 |
0.11 |
≡ |
Bill Nygren - Oakmark Select Fund |
Add 1.78% |
69,990 |
0.08 |
Q1  2022 |
≡ |
Samantha McLemore - Patient Capital Management |
Buy |
104,000 |
2.19 |
≡ |
Bill Miller - Miller Value Partners |
Add 1665.10% |
915,807 |
1.86 |
≡ |
Greenhaven Associates |
Add 18.66% |
844,900 |
1.20 |
≡ |
Warren Buffett - Berkshire Hathaway |
Buy |
55,155,797 |
0.81 |
≡ |
Kahn Brothers Group |
Add 8.77% |
78,359 |
0.53 |
≡ |
Leon Cooperman |
Reduce 50.00% |
190,000 |
0.53 |
≡ |
Bruce Berkowitz - Fairholme Capital |
Add 631.00% |
126,200 |
0.39 |
≡ |
Richard Pzena - Hancock Classic Value |
Add 9.09% |
170,742 |
0.31 |
≡ |
Lee Ainslie - Maverick Capital |
Sell 100.00% |
1,974 |
0.00 |
Q4  2021 |
≡ |
Greenhaven Associates |
Buy |
4,527,140 |
6.91 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 88.62% |
428,421 |
0.93 |
≡ |
Kahn Brothers Group |
Add 7.31% |
60,852 |
0.50 |
≡ |
Richard Pzena - Hancock Classic Value |
Add 12.87% |
214,258 |
0.42 |
≡ |
Bruce Berkowitz - Fairholme Capital |
Buy |
20,000 |
0.08 |
≡ |
Thomas Gayner - Markel Group |
Sell 100.00% |
21,020 |
0.02 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 94.86% |
36,440 |
0.00 |
Q3  2021 |
≡ |
ValueAct Capital |
Reduce 33.26% |
6,899,597 |
5.61 |
≡ |
Richard Pzena - Hancock Classic Value |
Add 20.74% |
285,954 |
0.70 |
≡ |
Bill Miller - Miller Value Partners |
Reduce 31.02% |
217,409 |
0.52 |
≡ |
Bill Nygren - Oakmark Select Fund |
Add 2.07% |
80,010 |
0.11 |
≡ |
Kahn Brothers Group |
Reduce 0.47% |
3,970 |
0.04 |
≡ |
Lee Ainslie - Maverick Capital |
Add 1307.62% |
35,685 |
0.03 |
Q2  2021 |
≡ |
Harry Burn - Sound Shore |
Sell 100.00% |
340,300 |
2.07 |
≡ |
ValueAct Capital |
Reduce 4.50% |
978,015 |
0.77 |
≡ |
Francis Chou - Chou Associates |
Reduce 14.77% |
10,000 |
0.41 |
≡ |
Kahn Brothers Group |
Add 0.72% |
6,023 |
0.06 |
≡ |
Steven Romick - FPA Crescent Fund |
Reduce 1.76% |
63,963 |
0.06 |
≡ |
Thomas Gayner - Markel Group |
Add 1.94% |
400 |
0.00 |
≡ |
Bill Miller - Miller Value Partners |
Add 0.19% |
1,306 |
0.00 |
≡ |
Lee Ainslie - Maverick Capital |
Reduce 76.60% |
8,931 |
0.00 |
Q1  2021 |
≡ |
Greenhaven Associates |
Sell 100.00% |
4,649,084 |
5.40 |
≡ |
ValueAct Capital |
Reduce 19.62% |
5,301,781 |
4.50 |
≡ |
Harry Burn - Sound Shore |
Reduce 52.00% |
368,600 |
2.24 |
≡ |
Richard Pzena - Hancock Classic Value |
Add 7.25% |
93,172 |
0.31 |